Shelter Pharma shareholders and shareholding pattern
BSE: 543963Pharmaceuticals & BiotechnologySmall Cap
SHELTER PHARMA LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2023
Last close ₹40.50up ₹0.90 (2.27%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹39.60.
29 Oct: open ₹40.50, high ₹40.50, low ₹40.50
52-week range of traded prices to 29 Oct 2026
₹23.00Low, 9 Jul 2026₹55.88High, 13 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹70 Cr3,366th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 7.76
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,000
Shelter Pharma's shareholding pattern for Oct 2026, filed on 23 Oct 2026: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Shelter Pharma, filing by filing
Per cent of the company's shares.
23 Oct 2026 filing
- Promoters46.11%
- Individuals and others53.89%
| Per cent | Oct 202623 Oct |
|---|---|
| 46.11% | |
| Indian promoters | 46.11% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 53.89% |
| Shares in issue | 1,73,01,792 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 12,76,789 |
| Promoters' shares locked in | 7,72,789 |
A dash is a line the filing did not state.
Shelter Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing of 23 Oct 2026; the largest is MUSTAQIM NISARAHMED SABUGAR, 13.25%.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| MUSTAQIM NISARAHMED SABUGARIndividuals and Hindu undivided families | 13.25% | 22,93,000 | 0.00% |
| SHAKIL NISARAHMED SABUGARIndividuals and Hindu undivided families | 13.07% | 22,61,000 | 12.62% |
| ZUBEDABIBI NISARAHMED SABUGARIndividuals and Hindu undivided families | 7.04% | 12,18,000 | 0.00% |
| SURAIYA M SAKIL SABUGARIndividuals and Hindu undivided families | 6.37% | 11,02,000 | 22.11% |
| DR.NUSRAT MUSTAKIM SABUGARIndividuals and Hindu undivided families | 6.37% | 11,02,000 | 22.11% |
| PARVEZBANU MOHAMED RAFIQ IDARIYAIndividuals and Hindu undivided families | 0.01% | 1,000 | 0.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Shelter Pharma, filing by filing
Per cent, on the same shares as the split above.
| Holder | Oct 202623 Oct |
|---|---|
| MISBAHUL MOHMED PANCHBHAIResident individuals, over ₹2 lakh at face value | 3.42% |
| RIFAT MISBAH PANCHBHAIResident individuals, over ₹2 lakh at face value | 3.10% |
| RISHABH NAYANBHAI SHARMAResident individuals, over ₹2 lakh at face value | 2.38% |
| APNEET KAHLON .Resident individuals, over ₹2 lakh at face value | 1.79% |
| QUARKS TECHNOSOFT PRIVATE LIMITEDCompanies | 1.77% |
| NURJAHA MOHAMEDYUSUF LALAResident individuals, over ₹2 lakh at face value | 1.73% |
| GURVINDER SINGH BHULLARResident individuals, over ₹2 lakh at face value | 1.60% |
| LALA MOHMADYUSUF GResident individuals, over ₹2 lakh at face value | 1.27% |
| SHAIKH SHABNAM MOHAMMEDRAFIQResident individuals, over ₹2 lakh at face value | 1.06% |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Oct 2026 filing
Against the Sep 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: QUARKS TECHNOSOFT PRIVATE LIMITED newly named at 1.77%; MARIYAMBIBI MOYUSUF AKULI no longer named, from 1.76%; GURVINDER SINGH BHULLAR newly named at 1.60%; 8 more moved